FALCO HOLDINGS Valuation

Q: What is the Fair Price of 4671 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

4671 (¥2280) is trading below our estimate of [[fair value]] (¥3620.23)

Is 4671 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4671 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4671 (¥2280) is trading below our estimate of fair value (¥3620.23)

Significantly Below Fair Value: 4671 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4671?

Key metric: As 4671 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4671. This is calculated by dividing 4671's market cap by their current earnings.
What is 4671's PE Ratio?
PE Ratio	13.3x
Earnings	JP¥1.83b
Market Cap	JP¥24.15b

4671 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	4.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 4671's PE Ratio compare to its peers?

The above table shows the PE ratio for 4671 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	78.8x
2372 I'rom Group	121.9x	n/a	JP¥31.5b
7840 France Bed HoldingsLtd	13.3x	n/a	JP¥42.7b
5127 GUPPY's	36x	33.0%	JP¥12.5b
6197 Solasto	144.2x	23.5%	JP¥43.6b
4671 FALCO HOLDINGS	13.3x	n/a	JP¥24.3b

Price-To-Earnings vs Peers: 4671 is good value based on its Price-To-Earnings Ratio (13.3x) compared to the peer average (78.8x).

Price to Earnings Ratio vs Industry

How does 4671's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 4671 is good value based on its Price-To-Earnings Ratio (13.3x) compared to the JP Healthcare industry average (14.2x).

Price to Earnings Ratio vs Fair Ratio

What is 4671's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4671 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	13.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4671's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

FINDEX

JP¥20.8b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

-0.7%

-12.5%

Suzuken

JP¥377.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,946.00

-2.6%

-1.6%

TOKAI

JP¥75.1b

Provides various healthy life services in Japan.

9729

JP¥2,214.00

0.05%

16.4%